-
EP2870180
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2870180
| EP2870180 - ANTI-BIOTIN ANTIBODIES AND METHODS OF USE [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 26.07.2024 Database last updated on 02.11.2024 | |
| Former | Grant of patent is intended Status updated on 01.04.2024 | ||
| Former | Examination is in progress Status updated on 08.10.2022 | Most recent event Tooltip | 26.07.2024 | (Expected) grant | published on 28.08.2024 [2024/35] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacher Strasse 124 4070 Basel / CH | [2024/35] |
| Former [2015/20] | For all designated states F. Hoffmann-La Roche AG Grenzacher Strasse 124 4070 Basel / CH | Inventor(s) | 01 /
BRINKMANN, Ulrich Feichtlstrasse 12 82362 Weilheim / DE | 02 /
GEORGES, Guy Am Berggraben 11 82392 Habach / DE | 03 /
GROTE, Michael Saelweiherstraße 15 82377 Penzberg / DE | 04 /
HOFFMANN, Eike Kienbachstrasse 1B 82211 Herrsching a. Ammersee / DE | [2015/20] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 4 81675 München / DE | [2024/35] |
| Former [2015/20] | Burger, Alexander Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52 82372 Penzberg / DE | Application number, filing date | 13734999.9 | 04.07.2013 | [2024/35] | WO2013EP64099 | Priority number, date | EP20120174957 | 04.07.2012 Original published format: EP 12174957 | [2015/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014006123 | Date: | 09.01.2014 | Language: | EN | [2014/02] | Type: | A1 Application with search report | No.: | EP2870180 | Date: | 13.05.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.01.2014 takes the place of the publication of the European patent application. | [2015/20] | Type: | B1 Patent specification | No.: | EP2870180 | Date: | 28.08.2024 | Language: | EN | [2024/35] | Search report(s) | International search report - published on: | EP | 09.01.2014 | Classification | IPC: | C07K16/44 | [2015/20] | CPC: |
C07K16/44 (EP,KR,RU,US);
A61K47/6801 (KR,US);
A61K47/6835 (EP,US);
C07K2299/00 (EP,KR,RU,US);
C07K2317/24 (EP,KR,RU,US);
C07K2317/31 (KR,US);
C07K2317/55 (EP,KR,RU,US);
C07K2317/56 (US);
C07K2317/565 (EP,KR,US);
C07K2317/92 (EP,KR,RU,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/20]
| Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | ANTI-BIOTIN-ANTIKÖRPER UND VERWENDUNGSVERFAHREN | [2024/16] | English: | ANTI-BIOTIN ANTIBODIES AND METHODS OF USE | [2015/20] | French: | ANTICORPS ANTI-BIOTINE ET PROCÉDÉS D'UTILISATION | [2024/16] |
| Former [2015/20] | ANTI-BIOTIN-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG | ||
| Former [2015/20] | ANTICORPS ANTI-BIOTINE ET PROCÉDÉS D'UTILISATION CORRESPONDANTS | Entry into regional phase | 04.02.2015 | National basic fee paid | 04.02.2015 | Designation fee(s) paid | 04.02.2015 | Examination fee paid | Examination procedure | 04.02.2015 | Examination requested [2015/20] | 10.08.2015 | Amendment by applicant (claims and/or description) | 09.02.2016 | Despatch of a communication from the examining division (Time limit: M04) | 13.04.2016 | Reply to a communication from the examining division | 30.06.2016 | Despatch of a communication from the examining division (Time limit: M04) | 26.10.2016 | Reply to a communication from the examining division | 17.10.2017 | Date of oral proceedings | 13.11.2017 | Despatch of communication that the application is refused, reason: substantive examination {1} | 13.11.2017 | Minutes of oral proceedings despatched | 07.10.2022 | Despatch of a communication from the examining division (Time limit: M04) | 15.02.2023 | Reply to a communication from the examining division | 02.04.2024 | Communication of intention to grant the patent | 12.07.2024 | Fee for grant paid | 12.07.2024 | Fee for publishing/printing paid | 12.07.2024 | Receipt of the translation of the claim(s) | Appeal following examination | 12.01.2018 | Appeal received No. T1171/18 | 21.03.2018 | Statement of grounds filed | 08.08.2022 | Result of appeal procedure: remittal for grant | 25.08.2022 | Despatch of the decision of the Board of Appeal | Divisional application(s) | EP18150996.9 / EP3339328 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 09.02.2016 | Fees paid | Renewal fee | 09.07.2015 | Renewal fee patent year 03 | 11.07.2016 | Renewal fee patent year 04 | 10.07.2017 | Renewal fee patent year 05 | 10.07.2018 | Renewal fee patent year 06 | 09.07.2019 | Renewal fee patent year 07 | 10.07.2020 | Renewal fee patent year 08 | 12.07.2021 | Renewal fee patent year 09 | 11.07.2022 | Renewal fee patent year 10 | 20.07.2023 | Renewal fee patent year 11 | 23.07.2024 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]WO0050088 (MILLENNIUM PHARM INC [US]); | [YD]WO0134651 (KS BIOMEDIX LTD [GB], et al); | Examination | WO2010056893 | by applicant | US4676980 | US4737456 | US4816567 | EP0404097 | EP0425235 | WO9301161 | US5208020 | WO9308829 | WO9316185 | WO9411026 | WO9429351 | US5416064 | US5500362 | US5571894 | US5587458 | US5624821 | US5635483 | US5648260 | US5648237 | WO9730087 | US5712374 | US5714586 | US5731168 | US5739116 | US5767285 | US5770701 | US5770710 | US5773001 | US5780588 | US5789199 | US5821337 | US5840523 | WO9858964 | US5869046 | US5877296 | WO9922764 | US5959177 | WO9951642 | US6040498 | WO0050088 | WO0061739 | US6171586 | US6194551 | WO0129246 | WO0134651 | US6248516 | US6267958 | WO0231140 | US6417429 | US6420548 | US2002164328 | WO03011878 | US2003115614 | US6602684 | US2003157108 | US6630579 | WO03085119 | WO03084570 | WO03085107 | US2004093621 | US6737056 | US2004110704 | US2004110282 | US2004109865 | US2004132140 | WO2004056312 | US2005014934 | WO2005035586 | WO2005035778 | US2005123546 | WO2005053742 | WO2005100402 | US2005260186 | US6982321 | US2006025576 | WO2006029879 | WO2006044908 | US2006104968 | US7087409 | US7125978 | US7332581 | US2008069820 | US7371826 | WO2008077546 | US7498298 | US7521541 | US7527791 | WO2009080251 | WO2009080252 | WO2009080253 | WO2009080254 | WO2009089004 | WO2010112193 | WO2010115589 | WO2010136172 | WO2010145792 | WO2010145793 | WO2011003557 | WO2011003780 | WO2011EP74273 |